Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.

Neoplasma

Volumn 54, Issue 1, 2007, Pages 7-15

  Milecki, P ^a   Kwias, Z ^a   Martenka, D J ^a  

^a First Clinic of Surgical Oncology   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

CLINICAL TRIAL; DRUG EFFECT; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RADIATION EXPOSURE; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, HORMONAL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATIC NEOPLASMS; RISK FACTORS; TREATMENT OUTCOME;

EID: 34250836311     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)